Ecological features of the association between mortality and determinants or salient risk factors of cardiovascular disease
Main Article Content
Abstract
The multifactorial emergence of the association between mortality and major risk factors of cardiovascular disease is not clearly established. Diverse countries have been monitoring and evaluating mortality and risk factors associated with cardiovascular disease as the levels and trajectories undergo continuous changes. Understanding the combined impacts of these alterations are crucial in taking precautionary measures in counteracting and managing cardiovascular disease. Mortality and risk factor data have been applied expansively for the monitoring and evaluation of cardiovascular disease issues and the spatiotemporal variations across populations. There are extant inequitable distribution of resources in the disparate regions and populations around the world in the quantification and analysis of the mortality, morbidity, risk factors or determinants of cardiovascular disease. The diagnosis of cardiovascular disease tends to be devoid of diagnostic tests of high specificity and sensitivity in certain instances. Poor diet is a leading etiologic factor of suboptimal health in cardiovascular disease. Diet, nutrition and scientific policy measures have accelerated, resulting in ambiguities, and also creating opportunities to obviate the excruciating health and economic burden in cardiovascular disease and other cardiometabolic disorders in vulnerable populations. These indicate that expansive spatiotemporal variations in the incidence between populations are attributable to inter alia certain contradictions in the modalities of event ascertainment, culture, and economic burden. This paper enhances and introduces novel issues, challenges and opportunities in the ecological presentations of the association between mortality and determinants or risk factors of cardiovascular disease.
Article Details
Section
The journal allows the author(s) to hold the copyright without restrictions and will retain publishing rights without restrictions.
The submitted papers are assumed to contain no proprietary material unprotected by patent or patent application; responsibility for technical content and for protection of proprietary material rests solely with the author(s) and their organizations and is not the responsibility of the journal. The main (first/corresponding) author is responsible for ensuring that the article has been seen and approved by all the other authors. It is the responsibility of the author to obtain all necessary copyright release permissions for the use of any copyrighted materials in the manuscript prior to the submission.
What are my rights as an author?
It is important to check the policy for the journal to which you are submitting or publishing to establish your rights as
Author. Journal's standard policies allow the following re-use rights:
- The journal allows the author(s) to hold the copyright without restrictions.
- The journal allows the author(s) to obtain publishing rights without restrictions.
- You may do whatever you wish with the version of the article you submitted to the journal.
- Once the article has been accepted for publication, you may post the accepted version of the article on your own personal website, your department's website or the repository of your institution without any restrictions.
- You may not post the accepted version of the article in any repository other than those listed above (i.e. you may not deposit in the repository of another institution or a subject-matter repository) until 12 months after publication of the article in the journal.
- You may use the published article for your own teaching needs or to supply on an individual basis to research colleagues, provided that such supply is not for commercial purposes.
How to Cite
References
Chukwuma Sr C and Tuomilehto J. Type 1 diabetes and coronary heart disease. Cardiovascular Risk Factors 1993;3(2): 129-37.
Chukwuma Sr C. Comorbid presentations and coronary heart disease risks with type 1 diabetes mellitus. Austin Medical Sciences 2019; 4(2): id1037.
Mendis S, Puska P and Norrving B. Global atlas on cardiovascular disease prevention and control. World Health Organization in collaboration with the World Heart Federation and the World Stroke Organization, 2011;3-18.
Moran AE, Forouzanfar MH, Roth GA, Ezzati M, Murray CJ and Naghavi M. Temporal trends in ischemic heart disease mortality in 21 world regions, 1980 to 2010: The Global Burden of Disease 2010 Study. Circulation 2014;129(14):1483-92.
Shanthi M, Pekka P and Bo N. Global atlas on cardiovascular disease prevention and control. World Health Organization, 2011.
The World Health Organization MONICA Project. Ecological analysis of the association between mortality and major risk factors of cardiovascular disease. Int J Epidemiol 1994; 23(3): 505-16.
Jenum AK, Stensvold I and Thelle DS. Differences in cardiovascular disease mortality and major risk factors between districts in Oslo. An ecological analysis. Int J Epidemiol 2001; 559-65.
Peasey A, Bobak M, Kubinova R, Malyutina S, Pajak A, Tamosiunas A, et al. Determinants of cardiovascular disease and other non-communicable diseases in Central and Eastern Europe. Rationale and design of the HAPIEE study. BMC Public Health 2006; 6 Article Number 255.
Thompson PL. J-curve revisited. Cardiovascular benefits of moderate alcohol use cannot be dismissed. Med J Austr 2013;198(8):419-22.
Lee C-Y and Lee Y-H. Measurement of socioeconomic position in research on cardiovascular health disparities in Korea: A systematic review. J Prev Med Public Health 2019; 281-91.
Rosengren A, Smyth A, Rangarajan S, Ramasundarahhettige C, Bangdowala SJ, Alhabib KF et al. Socioeconomic status and the risk of cardiovascular disease in 20 low-income, middle-income, and high-income countries: the prospective urban rural epidemiologic (PURE) study. The Lancet Global Health. 2019 DOI: https:// doi.org/10.1016/52214-109X(19)/30045-2.
Perisee G, Medronho R de A and Escosteguy CC. Urban space mortality from ischemic heart disease in the elderly in Rio de Janeiro. Arq. Bras. Cardiol 2010; 94(4)
Chukwuma Sr C and Tuomilehto J. Diabetes and the risk of stroke. J Diabetes & its Complications 1993;7(4): 250-62.
Mensah GA, Roth GA, Sampson UK, Moran AE, Felgin VL, Forouzanfar MH et al. Mortality from cardiovascular diseases in sub-Saharan Africa, 1990-2013: a systematic analysis of data from the Global Burden of Disease study 2013. Cardiovascular J Afr 2015; 26(2 Suppl 1): S6-10.
Sardarinia S, Akbarpour S, Lotfaliany M, Bagherzadeh K, Bozorgmanesh M, Sheikholeaslami F et al. Risk factors for incidence of cardiovascular diseases and all cause mortality in a middle eastern population over a decade follow-up: Tehran lipid and glucose study. PLoS ONE 2016; 11(12): eo167623.
Antikainen RL, Moltachanov VA, Chukwuma Sr C, Kuulasmaa KA, Marques-Vidal PM, Sans S et al. Trends in the prevalence, awareness, treatment and control of hypertension: the WHO MONICA Project. Eur J Cardiovascular Prev Rehabil 2006;13(1):13-29.
Liu L, Yin X, Chen M, Jia H, Eisen HJ and Hofman A. Geographic variation in heart failure mortality and its association with hypertension, diabetes and behavioral-related risk factors in 1,723 counties of the United States. Front Public Health 2018 https://doi.org/10.3389/fpubh.2018.00132
Wolska A, Lo L, Sviridov DO, Pourmusa M, Pryor M, Ghosh SS et al. A dual apolipoprotein C-II mimetic - apolipopritein C-III antagonist peptide lowers plasma triglycerides. Science Translation Medicine, 2020; 12(528): eaaw7905.
Yang WS, Chen Y-Y, Chen P-C, Hsu H-C, Chen N-F et al. Association between plasma N-6 polyunsaturated fatty acid levels and the risk of cardiovascular disease in a community-based cohort study. Sci Rep.2019; 9:19298.
Gunnarsdottir O, Birgisdottir, Benediktsson R, Gudnasson V and Thorsdottir I. Association between size at birth, truncal fat and obesity in adult life and its contribution to blood pressure and coronary heart disease: study in a high birth weight population. Eur J Clin Nutr 2004; 58: 812-8.
Chukwuma Sr C. Evaluating baseline data for trace elements, pH, organic matter content, and bulk density in agricultural soils in Nigeria. Water, Air, Soil Pollution 1996;86(1-4): 13-34.
Chukwuma Sr C. Environment and social consequences of metals and mines on water. Int J Env Studies 1998; 54(1A):73-81.
Evrard AS, Bouaoun L, Champelovier P, Lambert J and Laumon B. Does exposure to airport noise increase the mortality from cardiovascular disease in the population living in the vicinity of airports? Results of an ecological study in France. Noise Health 2015;17: 328-36.
Chukwuma Sr C. Environmental lead exposure in Africa. Ambio - Journal of the Human Environment 1997; 26(6); 399-403
Kumar S. Cardiovascular disease and its determinants: Public health issues. J Clin Med Ther 2017; 2:1.
Bhatnagar A. Environmental determinants of cardiovascular disease. Circ Res 2017; 121(2):162-80.
European Society of Cardiology - ESC. Most cardiovascular events and deaths are explained by risk factors. PURE Results ESC Congress 2019 together with WCC, O3 Sept 2019; European Society of Cardiology, Paris, France.
Ravnskov M, de Lorgeri IM, Diamond DM, Haina R, Hamazaki T, Hammarskjold B et al. LDL-C does not cause cardiovascular disease: a comprehensive review of the current literature. Expert Rev Clin Pharm 2018;11(10): 959-70.